FDA.reportPublic FDA data

efmoroctocog alfa 1 UNT Injection [Eloctate]

RxCUI
1719611
RxNorm name
efmoroctocog alfa 1 UNT Injection [Eloctate]
Display name
efmoroctocog alfa 1 UNT Injection [Eloctate]
Full name
efmoroctocog alfa 1 UNT Injection [Eloctate]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125487EloctateAntihemophilic Factor (Recombinant), Fc Fusion protein351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
e1419c33-ef07-4268-be1f-c8993502d597efmoroctocog alfa 1 UNT Injection [Eloctate]SBD10These highlights do not include all the information needed to use ELOCTATE ® safely and effectively. See full prescribing information for ELOCTATE. ELOCTATE ® [Antihemophilic factor (recombinant), Fc fusion protein], Lyophilized powder for solution for intravenous injection Initial U.S. Approval: 201420230505
e1419c33-ef07-4268-be1f-c8993502d597ELOCTATE 1 UNT InjectionPSN10These highlights do not include all the information needed to use ELOCTATE ® safely and effectively. See full prescribing information for ELOCTATE. ELOCTATE ® [Antihemophilic factor (recombinant), Fc fusion protein], Lyophilized powder for solution for intravenous injection Initial U.S. Approval: 201420230505
e1419c33-ef07-4268-be1f-c8993502d597Eloctate 1 UNT InjectionSY10These highlights do not include all the information needed to use ELOCTATE ® safely and effectively. See full prescribing information for ELOCTATE. ELOCTATE ® [Antihemophilic factor (recombinant), Fc fusion protein], Lyophilized powder for solution for intravenous injection Initial U.S. Approval: 201420230505